AI assistant
Sending…
Catheter Precision, Inc. — Director's Dealing 2021
Feb 6, 2021
35479_dirs_2021-02-05_ced89885-e0fb-40ab-ae1b-3d1c49fe3645.zip
Director's Dealing
Open in viewerOpens in your device viewer
SEC Form 3 — Initial Statement of Beneficial Ownership
Issuer: Ra Medical Systems, Inc. (RMED)
CIK: 0001716621
Period of Report: 2021-01-31
Reporting Person: Meline Susanne (Director)
Holdings (Non-Derivative)
| Security | Shares | Ownership |
|---|---|---|
| Common Stock | 1808 | Direct |
| Common Stock | 40000 | Indirect |
Holdings (Derivative)
| Security | Exercise Price | Expiration | Underlying | Shares | Ownership |
|---|---|---|---|---|---|
| Warrants (right to buy) | $11.25 | 2025-05-22 | Common Stock (88888) | Indirect | |
| Warrants (right to buy) | $8.75 | 2025-08-03 | Common Stock (68571) | Indirect |
Footnotes
F1: Securities are owned by Catalysis Partners ("CP"). The reporting person has an investment interest in CP through her IRA and, together with an immediate family member, owns a controlling interest in Francis Capital Management, LLC, which also has an investment interest in CP and serves as both its Managing Member and Investment Manager. The reporting person disclaims beneficial interest of these securities except to the extent of her pecuniary interest therein.
More from Catheter Precision, Inc.
Capital/Financing Update
2026
Jun 8
Earnings Release
2026
May 18
Interim / Quarterly Report
2026
May 18
Annual Report
2026
Apr 30
Earnings Release
2026
Mar 31
Annual Report
2026
Mar 31
Proxy Solicitation & Information Statement
2026
Mar 23
Proxy Solicitation & Information Statement
2026
Mar 23
Director's Dealing
2026
Feb 18
Major Shareholding Notification
2026
Feb 13